
MARST-BL
Bilastine 20 mg + Montelukast 10 mg
A dual-action anti-allergic tablet combining Bilastine and Montelukast for effective relief from allergic rhinitis and related symptoms.
MARKHZ Biosciences LLP develops and markets quality pharmaceutical products across anti-diabetic, anti-hypertensive, gastro care and anti-allergic therapies — supporting physicians and patients with reliable, science-led care.

Headquartered in Bengaluru, MARKHZ Biosciences LLP partners with GMP-certified manufacturing units to deliver rigorously tested formulations for chronic and acute conditions. From diabetes management to cardiovascular, gastro and allergy care — our portfolio is designed to support modern therapeutic needs.
Learn more about MARKHZFormulations manufactured at GMP-certified facilities with rigorous quality checks at every stage.
Evidence-based combinations across chronic and acute care therapeutic segments.
Products designed for tolerability, adherence and everyday accessibility.
Growing distribution network serving healthcare professionals across the country.
A snapshot of our therapeutic portfolio across diabetes, hypertension and gastro care.

Bilastine 20 mg + Montelukast 10 mg
A dual-action anti-allergic tablet combining Bilastine and Montelukast for effective relief from allergic rhinitis and related symptoms.

Glimepiride 1 mg + Metformin 500 mg (SR)
Sustained-release combination of Glimepiride and Metformin for improved glycemic control in Type 2 Diabetes.

Glimepiride 2 mg + Metformin 500 mg (SR)
Higher-strength sustained-release Glimepiride and Metformin combination for advanced Type 2 Diabetes management.
Six reasons healthcare professionals and distribution partners choose MARKHZ Biosciences.
Every formulation is produced at WHO-GMP certified manufacturing partners with full regulatory compliance.
Multi-stage in-process and finished-product testing ensures batch-to-batch consistency.
Portfolio built around evidence-based, guideline-aligned drug combinations for real therapeutic value.
We work closely with healthcare professionals to design products that support prescribing confidence.
Consistent availability across our expanding pan-India distribution network.
Honest labeling, responsible communication and strict adherence to pharma regulations.
“MARKHZ has consistently supplied quality formulations with dependable documentation and batch consistency. Their science-led approach and responsive support make them a reliable partner for our distribution network.”
To make quality medicines accessible by combining scientific rigour with reliable manufacturing partnerships.
To become a trusted name in Indian pharmaceuticals, known for quality, ethics and patient outcomes.
Distribution, medical enquiries and business partnerships.